1

INTRODUCTION

GLP1 medications have transformed obesity treatment.
For many patients, they are the first therapy that finally makes weight loss feel possible — not like a constant battle against hunger, cravings, and biology.

But most people don’t understand how these medications work, why they’re so effective, or how they differ from one another.

This article breaks down the science clearly and simply, so you understand exactly what GLP1 medications do, who they help, and how they fit into longterm metabolic care.

‍

1. What GLP1 Medications Are — and Why They Matter

GLP1 stands for glucagonlike peptide1, a hormone your gut naturally releases after eating.

It signals:

• “I’m full.”
• “Slow down digestion.”
• “Lower blood sugar.”
• “Stop cravings.”

People with obesity often have blunted GLP1 responses, meaning they don’t feel full as strongly or as quickly.

GLP1 medications restore and amplify this natural signal.

What GLP1 medications do:

• Reduce hunger
• Reduce cravings
• Slow gastric emptying
• Improve insulin sensitivity
• Lower blood sugar
• Reduce inflammation
• Support longterm weight loss

They treat obesity as the metabolic disease it is — not a willpower problem.

‍

2. Wegovy (Semaglutide)

FDAapproved for:

• Chronic weight management
• Obesity
• Overweight with comorbidities

How it works:

• Strong GLP1 activation
• Powerful appetite suppression
• Significant reduction in cravings
• Slower gastric emptying
• Improved insulin sensitivity

Expected weight loss:

• 15–20% of total body weight

Dosing:

• Weekly injection
• Gradual dose escalation

Who it’s best for:

• Patients needing strong appetite control
• Patients with emotional or binge eating
• Patients with insulin resistance or prediabetes

Wegovy is one of the most powerful nonsurgical weightloss medications ever developed.

‍

3. Zepbound (Tirzepatide)

FDAapproved for:

• Obesity
• Overweight with comorbidities

What makes it unique:

Zepbound activates two hormones:

• GLP1
• GIP (glucosedependent insulinotropic polypeptide)

This dual action creates a stronger metabolic effect.

Expected weight loss:

• 20–25% of total body weight
  Often approaching sleevelevel results.

How it works:

• Reduces hunger
• Reduces cravings
• Improves insulin sensitivity
• Enhances fat loss
• Improves metabolic markers

Who it’s best for:

• Patients with significant insulin resistance
• Patients with higher BMI
• Patients needing stronger metabolic improvement

Zepbound is currently the most powerful weightloss medication available.

‍

4. Saxenda (Liraglutide)

FDAapproved for:

• Chronic weight management

How it works:

• Daily GLP1 injection
• Moderate appetite suppression
• Moderate metabolic effect

Expected weight loss:

• 5–10% of total body weight

Who it’s best for:

• Patients who cannot tolerate stronger GLP1s
• Patients needing a gentler option
• Patients wanting daily dosing

Saxenda is effective, but less powerful than Wegovy or Zepbound.

‍

5. Ozempic vs. Wegovy — What’s the Difference?

Both contain semaglutide, but:

Ozempic

• FDAapproved for diabetes
• Lower maximum dose
• Weight loss is a secondary effect

Wegovy

• FDAapproved for obesity
• Higher maximum dose
• Designed specifically for weight loss

They are not interchangeable for insurance or medical purposes.

‍

6. How GLP1 Medications Actually Cause Weight Loss

1. They reduce hunger

Patients feel full sooner and stay full longer.

2. They reduce cravings

Especially for sugar and highreward foods.

3. They slow gastric emptying

Food stays in the stomach longer, enhancing satiety.

4. They improve insulin sensitivity

Lower insulin levels → less fat storage.

5. They reduce inflammation

Improves metabolic health.

6. They lower the body’s defended weight (setpoint)

This is the key to longterm success.

These medications treat the biology of obesity — not the behavior.

‍

7. Common Side Effects

Most side effects are gastrointestinal and improve over time:

• Nausea
• Bloating
• Fullness
• Constipation
• Diarrhea
• Fatigue

Slow dose escalation reduces symptoms significantly.

‍

8. Who Should Not Take GLP1 Medications

These medications are not appropriate for:

• Patients with personal/family history of medullary thyroid cancer
• Patients with MEN2 syndrome
• Patients with pancreatitis history (casebycase)
• Patients with severe GI motility disorders

A medical evaluation is essential before starting therapy.

‍

9. GLP1 Medications vs. Bariatric Surgery

GLP1s are powerful — but not as powerful as surgery for:

• Severe obesity
• Severe insulin resistance
• Severe metabolic disease
• Longterm durability

Best results often come from combining:

• Bariatric surgery
• GLP1 therapy
• Nutrition
• Strength training
• Longterm followup

They are complementary tools, not competitors.

‍

10. The Most Important Message: GLP1s Are Real Medical Treatment

These medications are not:

• Cheating
• Shortcuts
• Easy ways out

They are evidencebased metabolic therapy for a chronic disease.

Patients who respond well often say:

• “This is the first time I’ve felt in control.”
• “Food doesn’t dominate my thoughts anymore.”
• “I finally understand what normal hunger feels like.”

That’s not psychology.
That’s physiology working correctly.

‍

CONCLUSION

GLP1 medications like Wegovy, Zepbound, and Saxenda are powerful tools that treat obesity at its biological root.

They:

• Reduce hunger
• Reduce cravings
• Improve insulin sensitivity
• Lower the setpoint
• Support longterm weight loss

For many patients, they are lifechanging.

Understanding how they work — and how they differ — helps you choose the right tool for your biology, your goals, and your longterm health.